Is the level of aldosterone associated with mortality and acute ischaemic events in patients with CAD but without heart failure or acute MI?
Aldosterone levels may serve as an independent prognostic marker for mortality and acute ischemic events in stable CAD patients without heart failure or recent MI.
Our results demonstrate that, in patients with CAD but without heart failure or acute MI, the level of aldosterone is strongly and independently associated with mortality and the occurrence of acute ischaemic events.
Ivanés et al. (Thu,) studied this question.